524470 — Syncom Formulations (India) Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapHigh Flyer

Annual balance sheet for Syncom Formulations (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	477	745	1,356	934	1,167
Net Total Accounts Receivable
Net Total Receivables	676	833	1,140	1,288	1,175
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,398	1,817	2,748	2,700	3,304
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	527	688	723	775	898
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	3,082	3,778	4,047	4,133	5,338
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	783	1,132	1,062	593	1,037
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	860	1,218	1,165	711	1,189
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	2,222	2,560	2,881	3,422	4,150
Total Liabilities & Shareholders' Equity	3,082	3,778	4,047	4,133	5,338
Total Common Shares Outstanding